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Abstract. This contribution focuses on the heterogeneity and complexity of health 
information technology services and systems in a multi-stakeholder environment. 
We propose the perspective of process modeling as a method to break out 
complexity, represent heterogeneity, and provide tailored evaluation and 
optimization of health IT systems and services. Two case studies are presented to 
show how process modeling is needed to fully understand the information flow, 
thus identifying requirements and specifications for information system re-
engineering and interoperability; detect process weaknesses thus designing 
corrective measures; define metrics as a mean to evaluate and ensure system 
quality; and optimize the use of resources. 
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1. Complexity of healthcare and its impact on health-IT design and evaluation 
Our journey for being and staying healthy is complex [1], is life-long, involves multiple 
actors to cover our different needs, and, as with many other aspects of our life, is now 
supported by technology. Or this is what we expect.  
However, the concept of complexity should be defined more precisely: 
heterogeneous action sub-domains, dynamic evolution of knowledge, learning curves, 
indeterminacy, uncertainty, exceptions, transparency, and data protection are some of 
the features contributing to the concept of complexity that deserve some consideration 
[2]. 
In healthcare, two sub-domains of actions, the clinical sub-domain (devoted to 
patient care) and the administrative domain (devoted to the economic and financial 
aspects of care) share the same information regarding the patient, but need different 
views that focus on the specific data. For instance, in prescribing pharmacological 
treatments to patients, the active component, beneficial effects, side effects, adverse 
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events, and drug-drug interaction are clinically relevant to identify the prescribed drug, 
whereas the costs and reimbursement levels are relevant from the administrative 
viewpoint [3].  
The dynamic evolution of medical knowledge implies that any health IT system 
aimed at supporting medical decision-making not only has to deal with the available 
evidence-based medicine, but also has to be ready to dynamically and flexibly include 
new relevant evidence that may arise, personal experiences [4] and learning curves (i.e., 
learning by practice) [5]. 
In addition, uncertainty and indeterminacy [6] mainly arise from (1) the patient’s 
compliance and response to treatment that depend on the ability of patients to follow 
the instructions, their level of engagement, and health literacy; and (2) the ability of the 
patient to report the outcomes or complications of a treatment or therapy thus affecting 
the interpretation and judgment of the healthcare professionals responsible for it [7]. 
Also, the patient-centric approach in the design and development of health IT systems 
requires a level of personalization that may introduce “exceptions” and “deviations” 
from available clinical guidelines and recommendations, thus introducing another layer 
of “complexity”. 
Finally, the need of cooperation among different actors or roles within the 
patient/citizen care pathway [8] is translated into the need for a clear definition of roles, 
profiles, data views, and actions allowed, that could be summarized with the term 
“transparency”.  
All the features that we discussed so far show that the intrinsic complexity of the 
whole healthcare domain cannot be avoided and needs to be uncovered when designing, 
developing, and evaluating effective health IT systems and services. 
2. Heterogeneity of Health IT: Multiple systems and multiple actors  
The complexity of the healthcare domain is reflected in health IT systems that provide 
the technological support to the whole healthcare journey which is not limited to the 
periods when we are “patients”, but it spans across our whole life, with different needs. 
We therefore need to distinguish between the “citizen” who is not a patient until she/he 
receives a diagnosis, and the “patient” who suffers from a disease (with possible 
comorbidities).  
The classical healthcare pathway, that starts from prevention, until the patient 
receives a diagnosis, and then a treatment (or rehabilitation), can be seen from the two 
perspectives of the “patient” and the “citizen”. The citizen is the main actor in the 
prevention phase, but still contributes to the healthcare journey when involved as 
caregiver. Similarly, the patient is more active in the last two phases but also 
participates in the prevention phase, either to keep her/his pathology under control, or 
to avoid comorbidities.  
In this promising scenario, the patient and the citizen, despite being the main 
characters, are only two of the actors involved. Table 1 shows an attempt to represent 
the available health IT systems and services according to their main user profiles and 
the phase of the personal healthcare pathway. Whereas patients and families/caregivers 
have tools for all phases, the citizen is not considered as an active user profile in the 
treatment or rehabilitation phase. Other stakeholders are healthcare professionals and 
providers, the payers (public/private/insurances), and also students and researchers. Of 
course, for students and researchers, the tools are not specific for a phase of the 
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healthcare pathway but cover all of them. Even though not exhaustive, Table 1 depicts 
a heterogeneous environment, in which patient’s and citizen’s health depends on the 
intervention of different stakeholders who mainly need to collect relevant information 
regarding the patient’s/citizen’s conditions to take the right decisions. 
 
Table 1. Examples of health IT systems classified according to the main final user (rows) and the phase of 
the healthcare processes (columns). 
 
Prevention Diagnosis Treatment and Rehabilitation 
Citizens 
Diet monitoring 
Exercise 
monitoring 
Educational tools 
Personal Health 
Record (PHR) 
Communication with 
healthcare professionals 
Unsupervised symptom 
checkers 
e-services for checking 
symptoms  
Health information 
websites/apps 
 
 
Patients 
Telemonitoring & 
Sensors 
Environmental 
monitoring 
Educational tools 
Personal Health 
Record (PHR) 
e-services for checking 
symptoms  
Telediagnosis tools 
Portals for ranking/finding 
physicians 
 
Drug tracking systems 
Telerehabilitation systems 
Patient portals 
Family/Caregivers Activity trackers Educational tools 
Communication with 
healthcare professionals 
Drug tracking systems 
Telerehabilitation systems 
Community support tools 
Family Health Records 
Healthcare Professionals 
and hospitals/care centres 
Risk assessment 
tools 
Screening and 
Telescreening 
Decision Support 
Systems 
Electronic Health 
Record (EHR)  
 
Electronic Health Record 
(EHR) 
Supervised Symptom 
checkers 
Decision Support Systems 
Domain Ontologies and 
Knowledge representation 
systems 
Hospital Information System 
Reference databanks 
Biosignal/Bioimage 
Databanks 
Telecare systems 
Computer Interpretable 
Guidelines (CIGs) and 
Recommendations 
Electronic Health Record 
(EHR) 
Social care records and 
supporting systems 
Reference databanks 
Private/Public/insurance 
Payers 
Insurance-provided 
PHRs 
Risk assessment 
 
 
Health Information Systems Telecare systems 
Medical Students 
Visual knowledge tools 
Bioimage databanks 
Online reference systems 
Virtual environments 
Researchers 
Clinical report Forms (CRF) 
Shared Databanks 
Multicentre research platforms 
Reference databanks 
Crowdsourcing tools 
 
The number of different actors involved, the various levels of digitalization in 
different healthcare organizations, the processes implemented within these 
organizations, as well as their privacy and security policies and issues, contribute to 
create a scattered and heterogeneous scenario, in which information systems manage 
heterogeneous, and often redundant, information, with poor inter-communication, 
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caused by a lack of interoperability. This argues the need for appropriate tools able to 
break out such complexity thus providing tailored and effective evaluations and to 
follow the patient or citizen in a longitudinal, life-long, integrated perspective [9]. A 
process modeling approach provides such tools.  
3. Breaking out complexity and representing heterogeneity to provide tailored 
evaluation: the process modeling perspective 
Being an abstract representation of a process under examination, a model provides a 
clear representation of the actors, the roles, their tasks, their actions and resources, and 
tracks the information flow and the core phases throughout the process [10]. Hence, a 
model provides a clear and “transparent” view, in which all the complex features of the 
process are represented and analysed.  
Process modeling can be used both in the design phase of health IT systems, 
especially when the model is represented using standard languages for software design 
(e.g., the Unified Modeling Language, UML), and in the evaluation and re-engineering 
phase. In fact, the reliable, shared, transparent, and multi-level description of the 
process underlying the health IT system facilitates (1) the understanding of how a 
system works and how it can be integrated with other systems operating within the 
same process, and (2) the application of standard-based solutions. This ultimately 
supports interoperability and integration among different health IT systems [8] by:  
• Representing the impact of the single IT system on the process itself, thus 
providing an evaluation of the benefits introduced with the use of the system 
and its limitations 
• Comparing different IT systems, to establish which system better fits specific 
needs, in a given setting with specific constraints, in order to choose the most 
appropriate solution 
• Simulating the use of the IT system in another setting, by changing the local 
constraints and evaluating its possible impacts and effectiveness in different 
environments.  
The most important clinical benefits of the application of process modeling to 
health ITs are creating shared protocols based on clinical guidelines and local practices 
and monitoring the adherence to them; facilitating the communication among different 
actors and roles all contributing to patient’s care; highlighting process weaknesses and 
suggesting the applicable corrective measures; providing a clear view on the use and 
optimization of resources; fully understanding the information flow; and identifying 
requirements and specifications for information system re-engineering to promote 
interoperability [11]. 
Finally, models are usually represented in a graphical way that facilitates their 
sharing among the different actors involved, even though not expert in technologies 
and modeling. This implies that their multiple viewpoints can be involved in the 
evaluation (or design) of a system/service, thus enlarging the evaluation scenario and 
including the heterogeneous expertise, needs, and aims. 
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4. Basic principles of process modeling 
The integration between the skills and knowledge of domain experts and analysts is 
essential to model a healthcare process (Figure 1). Domain experts provide the 
experience on the field, and are aware of the existence of clinical guidelines and 
evidence-based practices related to the specific process. On the other hand, analysts are 
able to translate the experiences and knowledge of domain experts in a model, and 
from it to extract requirements and evaluation criteria. 
4.1. Basic steps 
The general approach to process modeling for health ITs is composed of three phases 
(Figure 1) - the analysis of the environmental context, the conceptual modeling, and the 
logical modeling. They are described as follows: 
 
1. The analysis of the environmental context includes the identification and 
analysis of the available sources of information (also evidence-based 
knowledge, international guidelines, and recommendations) and the 
understanding of the local domain in terms of local practices, and specific 
clinical pathways already in use locally. Focus groups and interviews with the 
medical staff or of the patient and caregivers highlight the personal experience 
of the actors involved in the process. This phase includes the analysis of the 
flow of information that is managed by the health IT system or service and its 
interaction (or need of interaction) with other existing systems, which is 
crucial to understand whether the data/information transmitted through the 
system under study is effectively used and received, and helps identifying the 
possible flaws. As part of this phase there is also the selection of the formal 
modeling notation (language, as, for example, the Unified Modeling Language 
– UML [12] or the Business Process Modeling Notation – BPMN [13]). 
 
2. The conceptual modeling includes a pre-modeling and a modeling phase. 
During pre-modeling it is important to provide a high-level process 
description (process phases) in terms of functional aspects (main activities of 
the process, objects and data items managed), organizational aspects (agents, 
roles, tasks, skills, availabilities, authorizations required to enact the process), 
actors’ responsibilities on the main activities, and business aspects (goals to be 
achieved). Outcomes have to be identified at this time, too. They can be either 
clinical outcomes (for example to evaluate a telemonitoring system) or 
functional or efficiency outcomes (for example to evaluate a booking system). 
The modeling phase produces the conceptual model of the process according 
to the formal notation adopted and comprises: the schema of the process with 
its variables, the specification of the expected exceptions and transactions, the 
access control model, and the representation of the information flow with 
external information systems. Thanks to the definition of the model, it is at 
this stage possible to define appropriate metrics, either to evaluate the process 
itself or to monitor the health IT service/tool that supports/implements the 
process. Domain experts act as feedback during the whole phase, to validate 
the model under construction. The validation, in fact, should not only verify 
whether the model is “syntactically” correct (internal consistency and usability 
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for system requirements definition), but also if it is “semantically” correct 
(validation of the information flow in the simplest activities of the process, 
and verification of the expectations of all the actors involved).  
 
3. The logical modeling is the final phase in which the model is implemented 
either in an executable modeling language, or as a full system (or system 
modules). In this phase it is important to design the possible solutions to the 
critical issues identified, or to highlight the requirements for system re-
engineering [11]. 
 
 
 
 
Figure 1. Basic modeling principles.  
 
4.2. Metrics and process evaluation  
A Metric is defined as “a quantitative measure of the degree to which a system, 
component, or process possesses a given attribute” [14] and it is based upon two or 
more measures. Metrics for the evaluation of health IT cannot be directly derived from 
the model itself. Models do not provide a direct means for cost-effectiveness or cost-
benefit analysis. However, the model can be the basis for identifying the outcome 
variables to be introduced into e-management techniques as metrics for evaluation. 
Moreover, as aforementioned, in order to deal with the overall heterogeneity of the 
healthcare processes and its stakeholders, not only metrics related to the economic 
factors must be considered. Health Technology Assessment (HTA) can represent a 
valuable approach for evaluating the single health IT system and for comparing it with 
different systems, since the HTA is a multidisciplinary and multidimensional approach 
for analyzing all the areas of interest (e.g. epidemiological, economic, social, ethical, 
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legal, organizational, and political implication) [15] 2. Nevertheless, HTA is not always 
supported by structured techniques for the evaluation and prioritization (i.e., multiple-
criteria decision analysis, such as the Analytic Hierarchy Process - AHP [16]).  
Besides the prioritization and evaluation of the overall health IT systems, the 
processes behind it need to be monitored identifying the best metrics, and the proper 
time when they need to be measured for process evaluation. Indeed, the major 
regulations and directives for hospital accreditation and certification (e.g., Joint 
Commission International, ISO 9001:2008) require to define and model processes, and 
to identify the most appropriate performance measures (where performance 
measurement is defined as “a system for assessing performance of development 
interventions against stated goals” [17]) that can be organized in metrics. Nevertheless, 
they do not always specify how to define and collect performance measures and, 
consequently, metrics. 
On the other hand, the application of process improvement techniques is rapidly 
growing in the healthcare context, and approaches originally linked to manufacturing 
areas (i.e., Lean Management) are being recently extended also to hospitals. Lean 
Management techniques suggest metrics for evaluating a process and its wastes (the 
“Lean Key Performance Metrics”), such as On-Time Delivery, Customer Lead Time 
Reduction, Inventory Turns, and Overall Efficiency Percentage Gains. Nevertheless, 
some of these metrics lack a unique definition, especially in the healthcare context. 
Another technique for identifying metrics of interest that overcomes the limitations 
described above, is the Goal Question Metrics (GQM) [18]. The GQM allows selecting 
metrics with a top-down and goal-oriented approach, and it can be exploited for 
gathering the measurement data and driving decision-making and improvements, 
providing a support for the identification of the metrics starting from the definition of 
goals. The definition of the goals during the initial conceptual modeling of the process 
facilitates the implementation of the GQM. Specifically, the GQM can be divided into 
three levels: Goal (Conceptual level, defines the main purposes of a work to be 
measured); Question (Operational level, defines a set of questions useful for achieving 
the goals); Metric (Quantitative level, defines a set of metrics for answering the 
questions in a measurable way). The GQM is a versatile approach and can be 
considered a useful technique for defining metrics of health IT. 
5. Case studies 
This section presents two case studies, chosen to instantiate the considerations 
discussed in the previous parts of this contribution. The first case study looks at the use 
of process modeling to represent e-prescribing systems, providing a model-based 
evaluation framework able to identify the aims and needs of different systems, and to 
identify the gaps that require re-engineering [3].  
The second case study shows the evaluation of the system for managing the 
pathway for cancer patients. Process modeling in this case was able to highlight an 
information loss in the ambulatory setting that does not impact the clinical outcome of 
the patients but the treatment reimbursement (administrative perspective, unpublished 
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research), and led to the development of a new module of the hospital information 
system able to manage the information loss during the day care process.  
5.1. Model-based representation of e-prescribing systems 
E-prescribing is a complex process that differs from the simplistic idea of “transmitting 
a digital prescription to the pharmacy” [19]. It is a closed-loop process that starts from 
the decision of which treatment to prescribe to the patient and ends with the patient’s 
clinical outcomes, with adverse events and clinical outcomes as feedback variables 
[19]. Heterogeneous e-prescribing systems are available worldwide, with different 
aims, in different contexts, and processing different information. This varied scenario 
claims for a reliable framework for the representation of different e-prescribing systems 
and for the evaluation of the benefits associated to their introduction [3].  
For this reason, in cooperation with the Italian Government and in the framework 
of the Italian digitalization program for the Public Administrations entities (DigitPA), 
the modeling approach was applied to the e-prescribing process in order to (1) 
understand the possible benefits gained by the introduction of an e-prescribing system, 
and (2) compare existing e-prescribing solutions in terms of benefits for the healthcare 
system.  
The modeling steps reported in Figure 1 were followed to create the e-prescribing 
model described in [3]: after the environmental context phase, which included also the 
direct interaction with the Italian Ministry of Health, the conceptual modeling phase 
provided the high-level meta-model (activity diagram), the identification of the 
interacting systems and tools, the definition of the expected outputs from each activity, 
and the definition of the evaluation outcomes in terms of expected benefits (Figure 2). 
For details about the model, see [3]. 
The evaluation framework was based on the verification of the correct 
implementation of specific functions that were called “verification actions”. In each 
phase of the process, the model defines these “verification actions” that guarantee a 
specific benefit, with a fine granularity. For example, during the first phase of the 
process (i.e., Assign phase, when the treatment is prescribed to the patient, Figure 2A), 
if the e-prescribing system verifies the existence of a coded diagnosis in the 
prescription document, we can expect two kinds of benefits: (1) that the drug is 
assigned with a valid clinical reason (quality of care dimension, increased patient’s 
safety), and (2) that the relationship drug-diagnosis is tracked and can be used for drug 
surveillance (efficiency of care dimension). In a similar way, if the e-prescribing 
system guarantees the verification of drug-drug interactions, we can expect a decreased 
risk of undesired adverse drug events (ADEs) or altered outcomes due to the interaction 
of the prescribed drug with others already in use (quality of care dimension). For the 
full description of each verification action and its expected benefit, see [3]. 
Aimed at providing a framework for evaluating and comparing e-prescribing 
systems, the modeling effort ended at this point. So, the presence/absence of model 
elements (i.e., verification actions) was used to compare the potential benefits 
introduced by three e-prescribing systems, namely the Lombardy Region (Italy), the 
Andalusia Region (Spain), and the Italian Government. The analysis, that is fully 
reported in [3], showed that all systems lack the connection between the first three 
phases (from “assign” to “delivery”) and the administration phase, when the patient is 
at home, thus suggesting that the available e-prescribing systems fail in integrating the 
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patient as an active user and lose important information on drug administration and 
effect monitoring. 
 
  
Figure 2. (A) High-level meta-model representing the main process phases.  
(B) Expected benefits dimensions from the adoption of e-prescribing (adapted from [3]). 
 
However, the model as it is also represents the basis for metrics definition, as a 
mean to ensure system quality. As an example, we can consider the “verification 
actions” identified by the model for the first process phase (“assign phase”). Each of 
them is associated with a set of benefits that, in terms of GQM (as explained above), 
which we can consider as the goals identified by the model that require metrics 
definition.  
Table 2 presents a proposal of numeric metrics that can be used to evaluate the 
quality of both the e-prescribing system under examination and the e-prescribing 
process itself. For instance, in the case of “drug-drug interactions check”, the benefit 
measure can be the number of reported ADEs before and after the adoption of the e-
prescribing system under examination; in the case of “summary of product 
characteristics and diagnosis” the adopted metrics can be the number (or %) of 
prescriptions with reported diagnosis/drug pair in accordance with indications that not 
only show whether the e-prescribing system is able to support the assignment of drugs 
according to guidelines but also helps identifying cases of drug misuse.  
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Quality of care 
dimension  
• Improved awareness of 
citizens about their 
health (better-informed 
citizens). 
• Timeliness of care 
delivery. 
• Patient’s safety that 
includes, for example, 
the reduced risk of 
adverse events. 
• Streamlined care that 
ensures a direct 
approach to care. 
• Modernized care that 
include engaged 
patients in care 
pathways. 
Access to care 
dimension 
• Improved equity of 
access to healthcare for 
all those in need, who 
have the same right to 
receive adequate care. 
• Access to healthcare 
delivery for citizens 
who previously had no 
access. 
Efficiency of care 
dimension 
• Improvement of 
productivity. 
• Limitation of resource 
waste. 
• Improved allocation of 
resources. 
• Improved use of 
resources.
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Table 2. E-prescribing assign phase: verification actions, their associated benefits and metrics. 
VERIFICATION 
ACTIONS IN THE 
ASSIGN PHASE 
BENEFITS FOR 
QUALITY OF 
CARE 
BENEFITS 
FOR ACCESS 
TO CARE 
BENEFITS FOR 
EFFICIENCY OF 
CARE 
POSSIBLE 
METRICS 
 
Valid patient 
(patient validation) 
Identity error 
avoided 
Ensures patient’s 
existence within 
the National 
Healthcare 
System 
Avoided time waste due 
to erroneous patient’s 
identification 
Number (or %) of 
prescriptions with 
incorrect, missed or 
unknown patient ID 
Valid exemptions 
rights  
Ensures that the 
patient has the 
right of an 
exemption 
Possibility to analyze the 
relationship between a 
prescribed drug and a 
certain exemption, thus 
preventing possible 
frauds. 
Number (or %) of 
prescriptions with: 
- Invalid exemption 
code 
- Invalid patient 
ID/exemption code 
pair 
- Invalid exemption 
code /drug code pair 
Filled out diagnosis 
Ensures that the 
prescription is the 
result of a 
new/previous 
diagnosis 
 
Possibility to track the 
relationship between the 
diagnosis and a specific 
drug 
Number (or %) of 
prescriptions with: 
- Diagnosis reported 
- Correctly coded 
diagnosis reported 
Valid drug   
Ensures that the drug is 
included in the official 
national nomenclature 
Avoided time waste due 
to non-existent drug 
Number (or %) of 
prescriptions with 
valid drug code 
% of generic drug 
prescribed vs branded 
drugs 
Drug-drug 
interaction check 
Decreased risk of 
interactions with 
drugs already in 
use by the patient 
 
Possibility to have a 
more efficient alerting 
system of drug-drug 
interactions and ADEs 
reporting  
Number (or %) of 
prescriptions avoiding 
drug-drug interactions 
Number of reported 
ADEs 
Number of new ADEs 
identified 
Coherence between 
summary of 
product 
characteristics and 
diagnosis 
Decreased risk of 
incorrect drug 
assignment 
  
Number (or %) of 
prescriptions with 
reported 
diagnosis/drug pair in 
accordance with 
indications 
Valid GP 
identification   
Ensures that the GP is 
recognized by the 
healthcare system as 
having the right to 
prescribe 
Number (or %) of 
prescriptions with 
unknown or missed 
GP ID 
 
In conclusion, in this first case study, the analysis through a process modeling 
approach was able to (1) highlight what is still missing in existing systems (new tools 
for the safe and monitored drug administration at home connected to the e-prescribing 
systems) and (2) evaluating e-prescribing systems and processes by associating metrics 
to the modelled “verification actions” that represent the goals of e-prescribing in terms 
of benefits for the healthcare system.  
5.2. Health IT systems for supporting the chemotherapy care pathway for cancer 
patients  
Chemotherapy (CHT) is a crucial component of protocol-based care for cancer patients 
[20]. The process of prescription, preparation (dose calculation), and administration of 
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CHT is complex, because of the high toxicity of drug, and impacts on patient safety 
[21]. Errors may be caused by an inappropriate therapy prescribed or delivered, the 
presence of drug-drug interactions, or an incorrect dosage. Errors may also impact on 
cancer therapy costs that have been increasing dramatically over the last few years, and, 
consequently, on the economic sustainability of patient’s management for healthcare 
institutions [22]. The patient’s pathway within the hospital (the European Institute of 
Oncology (EIO), Milan, Italy) is supported by different health IT systems usually 
included in the hospital information system. However, the development of reliable 
health IT systems, capable to ensure proper management on the process and to prevent 
errors, is heavily grounded on the understanding of the underlying process.  
The modeling effort, in this case study, aimed to (1) to describe the care pathway 
involving cancer patients receiving chemotherapies or supportive therapies at the Day 
Care division for the EIO, and (2) to highlight the critical aspects of the care pathway 
and, at the same time, to provide possible solutions for them. 
The modeling methodology is summarized in Figure 3. 
 
 
Figure 3. Modeling steps for the evaluation of the chemotherapy care pathways for cancer patients. 
 
The first phase, the Analysis of Environmental Context, mainly consisted of field 
work, and lasted three months during which clinical and administrative practices, 
locally applied, were observed in presence (with attention to the clinical records 
pathway and information technology used). During the Conceptual Modeling, a high-
level meta-model (pre-modeling) was used to identify the main activities, their sub-
activities, and exceptions. The pre-model was then designed and validated during 
meetings with medical experts and administrative staff, during which misalignments 
with the proposed guidelines were also evaluated. The modeling phase involved the 
creation of UML structural and behavioural diagrams that were again validated both 
syntactically by the analyst experts and semantically by domain experts. The logical 
modeling phase, in this case, involved the "Critical Issues Identification", consisting of 
an analysis of each activity, represented on diagrams, that allowed highlighting process 
inefficiencies and their causes. From these, solutions that may allow a process 
reengineering, able to adapt the new models to the ongoing processes, were identified.  
The model-based analysis identified the drugs reimbursement flow (called “File F 
flow”) as one of the most critical processes in the patient’s pathway. The main 
observed critical issues were associated with untracked information within the pathway 
(Figure 4). In fact, the pathway starts with the patient who has a prescription for 
chemotherapy and is admitted to the ambulatory process. The prescription is used to 
categorize the patient for the admission regimen and to define the level of 
reimbursement associated to the patient, and registered in the “file F”. However, after 
DOMAIN 
ANALYSIS 
Field work at 
the Day 
Hospital Unit 
and Health 
Management 
Unit 
PRE-
MODELING 
Informal 
diagram design 
MODELING 
UML diagrams 
and Expert 
validation 
METRICS 
DEFINITION 
Measurements 
of the 
information 
loss in the drug 
reimbursement 
process 
DIAGNOSTIC 
• Interaction with 
Experts 
• Identification 
of weaknesses 
and untracked 
information 
PROCESS RE-
DESIGN 
• Weaknesses 
analysis 
• Specifications 
for software 
solution. 
ENVIRONMENTAL 
CONTEXT ANALYSIS 
CONCEPTUAL 
MODELING 
LOGICAL 
MODELING 
S. Marceglia et al. / Domains of Health IT and Tailoring of Evaluation 73
the first tests done by the nurse and the medical exam done by the oncologist specialist, 
the patient can be assigned to a therapy different from the one prescribed but more 
suitable for his/her current condition. This can affect the reimbursement and, in turn, 
the “file F flow”. The conceptual modeling of the process currently implemented 
highlighted other information loss in the “file F” tracking: the difference between the 
admission regiment and the prescription, the loss of paper-based documentations for 
reimbursement request, and the loss of drug information for reimbursement after 
patient’s visit. The process, in fact, didn't track the decision-making during the patient’s 
visit (due to the lack of an appropriate information system) and the documentation 
running in the patient’s pathway was not updated after establishing the patient's 
condition. This produced the lack of association between Reimbursement Rules (in the 
patient’s electronic health record) and Administered Therapy (in a different paper-
based record), and, in turn, no drug reimbursement for the hospital. 
 
Figure 4. Pre-modeling: high-level UML-like activity diagram representing the care pathway with critical 
issues identified. Smileys represent process actors; sketches represent the interaction of actors with the 
available information systems. 
Based on these considerations, a new model was created as a solution for the 
critical issues. The new model provided the technical specifications for the creation of a 
new module of the hospital information system that allows monitoring and controlling 
process variables, promoting operator coordination and integration, and optimizing the 
collaboration between operating units.  
The goal of modeling in this case study was to limit the information loss for the 
drug reimbursement process. Also in this case, it is possible to identify metrics to 
evaluate whether or not the proposed solution satisfied such expectation. They can be, 
for example: 
• the number of inconsistencies between the expected reimbursements and the 
obtained reimbursement; 
• the number of incomplete “file F” for the patients treated. 
 
In conclusion, in this case study, the modeling effort was able to provide a full 
representation of the complex process of the chemotherapy care pathway for cancer 
patients (with a translational value for hospitals other than the EIO), allowed the 
identification of the main critical issues underlying process inefficiencies and the 
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creation of a feasible solution to the identified critical issues, and grounded the 
definition of metrics to evaluate the efficiency of the proposed solution. 
6. Conclusions 
This contribution presented the heterogeneity and complexity of health IT services and 
systems that are a consequence of the heterogeneity and complexity characterizing the 
healthcare domain. We proposed the perspective of process modeling as a method to 
break out complexity and represent heterogeneity and to provide tailored evaluation 
and optimization of health IT systems and services. Process modeling not only provides 
a way to effectively represent the requirements of a system or service. By also 
supporting the identification of goals and benefits, it allows the definition of 
quantitative metrics able to show whether a system is suitable for a specific context, 
also in terms of economic revenue/savings [23].  
Recommended further readings 
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Food for thought 
1. To what extent is modeling needed for defining metrics? 
2. Is the personalization of care only a matter of exceptions to a generic model, or is 
it a specialization of a general model? How do we map personalization when 
modeling is done for requirement analysis? 
3. Is process modeling able to represent the local environment without losing its 
generalizability? How can we ensure that models are portable in different 
environments? 
4. Does a model designed for a specific context have a predictive value in 
establishing metrics for specific contexts for which the model has not been 
specialized yet? 
S. Marceglia et al. / Domains of Health IT and Tailoring of Evaluation 75
References 
[1]  M.R. McGee-Lennon, Requirements engineering for home care technology, in: Proceedings of the 
SIGCHI Conference on Human Factors in Computing Systems 2008, April 5–10, 2008, Florence, Italy. 
ACM, New York, 2008. pp. 1439-1442. 
[2]  E.H. Shortliffe, G.O. Barnett, Biomedical Data: Their Acquisition, Storage, and Use, in: Biomedical 
Informatics, Springer-Verlag, London, 2014, pp. 39–66. 
[3]  S. Marceglia, L. Mazzola, S. Bonacina, P. Tarquini, P. Donzelli, F. Pinciroli, A comprehensive e-
prescribing model to allow representing, comparing, and analyzing available systems, Methods of 
Information in Medicine 52 (2013), 199–219. 
[4]  H.S. Barrows, R.M. Tamblyn, Problem-based learning: an approach to medical education, Springer, 
New York,1980. 
[5]  R.J. Scalese, V.T. Obeso, S.B. Issenberg, Simulation Technology for Skills Training and Competency 
Assessment in Medical Education, Journal of General Internal Medicine 23 (2008), 46-49. 
[6]  R. Lenz, M. Reichert, IT support for healthcare processes – premises, challenges, perspectives, Data & 
Knowledge Engineering 61 (2007), 39-58. 
[7]  G. Kotronoulas, N. Kearney, R. Maguire, A. Harrow, D. Di Domenico, S. Croy, S. MacGillivray, 
What is the value of the routine use of patient-reported outcome measures toward improvement of 
patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review 
of controlled trials, Journal of clinical oncology 32 (2014), 1480–1501. 
[8]  M. Ozkaynak, P. Brennan, An observation tool for studying patient-oriented workflow in hospital 
emergency departments, Methods of Information in Medicine 52 (2013), 503–513. 
[9]  B. Séroussi, M.C. Jaulent,, C.U. Lehmann, Health Information Technology Challenges to Support 
Patient-Centered Care Coordination, Yearbook of Medical Informatics 10 (2015), 8-10.  
[10]  P. Lawrence, Ed., Workflow handbook 1997, Wiley, Chichester, 1997. 
[11]  S. Mohapatra, Business process reengineering: automation decision points in process reengineering, 
Springer, New York, 2013. 
[12]  H.-E. Eriksson, Business modeling with UML: business patterns at work, John Wiley & Sons, New 
York, 2000. 
[13]  F. Ruiz, F. Garcia, L. Calahorra, C. Llorente, L. Gonçalves, C. Daniel, B. Blobel, Business process 
modeling in healthcare, Studies in health technology and informatics 179 (2012), 75–87. 
[14]  G. Pozzi, S. Morasca, A. Antonini, A.M. Ferreira, Software Measures for Business Processes, in: 
ADBIS 2011 - Research Communications, CEUR Workshop Proceedings, Aachen, Germany, 2011. pp. 
11-22. 
[15]  A. Kazanjian, C.J. Green, Beyond effectiveness: the evaluation of information systems using a 
comprehensive health technology assessment framework, Computers in biology and medicine 32 
(2002), 165–177. 
[16]  L. Pecchia, F. Crispino, S.P. Morgan, A Software Tool to Support the Health Technology Assessment 
(HTA) and the User Need Elicitation of Medical Devices via the Analytic Hierarchy Process (AHP), 
in: The International Conference on Health Informatics, Springer International Publishing, Switzerland, 
2014, pp. 292–295. 
[17]  DAC Network on Development Evaluation, Glossary of key terms in evaluation and results based 
management, 2002, http://www.oecd.org/development/peer-reviews/2754804.pdf, last access 11 
February 2016. 
[18]  R. van Solingen, V. Basili, G. Caldiera, H.D. Rombach, Goal Question Metric (GQM) Approach, in: 
Encyclopedia of Software Engineering, John Wiley & Sons Inc., Hoboken, NJ, 2002. 
[19]  D.S. Bell, S. Cretin, R.S. Marken, A.B. Landman, A conceptual framework for evaluating outpatient 
electronic prescribing systems based on their functional capabilities, Journal of the American Medical 
Informatics Association 11 (2004), 60–70.  
[20]  E. Frei III, K. Antman, Principles of dose, schedule, and combination chemotherapy, in: Holland-Frei 
Cancer Medicine, BC Decker Inc, Hamilton, ON, 2000, pp. 556–568. 
[21]  M.N. Neuss, M. Polovich, K. McNiff, P. Esper, T.R. Gilmore, K.B. LeFebvre, L. Schulmeister, J.O. 
Jacobson, 2013 Updated American Society of Clinical Oncology/Oncology Nursing Society 
Chemotherapy Administration Safety Standards Including Standards for the Safe Administration and 
Management of Oral Chemotherapy, Oncology Nursing Forum 40 (2013), 225-233. 
[22]  J. Phillips, S. Beam, A. Brinker, C. Holquist, P. Honig, L.Y. Lee, C. Pamer, Retrospective analysis of 
mortalities associated with medication errors, American journal of health-system pharmacy 58 (2001), 
1835–1841. 
[23]  KLAS, Ultrasound 2014: Saving Time and Money with Workflow Automation, 2014.  
 
S. Marceglia et al. / Domains of Health IT and Tailoring of Evaluation76
